The link between SGLT1 inhibition and AQP, albeit in a non-CF model, was proposed in an early study using rat bile duct epithelial cells (i.e., cholangiocytes), in which the use of PHL activated AQP4.16 Here, SLC5A1 is linked to cystic fibrosis.